Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Large-scale testing (Phase 3)Study completedNCT01335828What this trial is testingElastography Interest in the Management of Thyroid NodulesWho this might be right forThyroid Nodules AdministrateurCIC 125
Not applicableUnknownNCT02462512What this trial is testingDiagnostic Performance of Ultrasound Elastography for Detection of Thyroid CancerWho this might be right forElastographyThyroid Nodule Dong Jun Lim 590
Not applicableStudy completedNCT06051838What this trial is testingPrognostic Value of Tumor Deposits for Patients With Papillary Thyroid CarcinomaWho this might be right forExploring the Prognostic Value of Tumor Deposits PTC Patients Nanfang Hospital, Southern Medical University 541
Testing effectiveness (Phase 2)Study completedNCT00654238What this trial is testingPhase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid CancerWho this might be right forMetastatic Differentiated Thyroid CancerMetastatic Poorly Differentiated Thyroid CancerMetastatic Anaplastic Thyroid Cancer+1 more University of Pennsylvania 59
Testing effectiveness (Phase 2)Ended earlyNCT00923247What this trial is testingA Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)Who this might be right forMedullary Thyroid Carcinoma National Cancer Institute (NCI) 22
Not applicableStudy completedNCT01907997What this trial is testingEffects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted ThyroidectomyWho this might be right forThyroid Cancer Yonsei University 90
Very early researchLooking for participantsNCT06632860What this trial is testingA Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive TumorsWho this might be right forIodine-resistant Thyroid CancerMeningiomaNETs Peking Union Medical College Hospital 40
Not applicableEnrolling By InvitationNCT07178080What this trial is testingComparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard UltrasoundWho this might be right forThyroid NodulesThyroid Nodule Sarasota Memorial Health Care System 75
Testing effectiveness (Phase 2)Study completedNCT00390325What this trial is testingSorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid CancerWho this might be right forHereditary Thyroid Gland Medullary CarcinomaLocally Advanced Thyroid Gland Medullary CarcinomaMultiple Endocrine Neoplasia Type 2A+8 more National Cancer Institute (NCI) 21
Not applicableStudy completedNCT01424878What this trial is testingStudy of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals PatientsWho this might be right forMedullary Thyroid CarcinomaMultiple Endocrine Neoplasia Type 2 National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT05851560What this trial is testingProspective Comparison of the Effect on Antiadhesive Barriers During Thyroid SurgeryWho this might be right forThyroidectomyGoiterThyroid Cancer National Taiwan University Hospital 45
Not applicableStudy completedNCT04139096What this trial is testingGenetic Susceptibility to Radiation Induced Thyroid CancerWho this might be right forThyroid NeoplasmsGenetic SusceptibilityRadiation Exposure Institut National de la Santé Et de la Recherche Médicale, France 60
Not applicableUnknownNCT04858867What this trial is testingReinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)Who this might be right forDifferentiated Thyroid Cancer Leiden University Medical Center 12
Testing effectiveness (Phase 2)WithdrawnNCT01994200What this trial is testingDeveloping and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer PatientsWho this might be right forThyroid Cancer Jewish General Hospital
Not applicableApproved For MarketingNCT04204928What this trial is testingPre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTCWho this might be right forNon-Small Cell Lung CancerMedullary Thyroid Cancer Blueprint Medicines Corporation
Not applicableNot Yet RecruitingNCT06845098What this trial is testingImpact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid CancerWho this might be right forThyroid Gland Zhejiang Provincial People's Hospital 300
Not applicableLooking for participantsNCT06455371What this trial is testingPatient-centered Dosage of LevothyroxineWho this might be right forHypothyroidismThyroid CancerThyroid University Hospital of North Norway 240
Not applicableEnded earlyNCT05014698What this trial is testingIDEntification of New Predisposition Genes in Differentiated THYroid CancerWho this might be right forDifferentiated Thyroid CancerThyroid Cancer, Nonmedullary Nantes University Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06235216What this trial is testingSacituzumab govitEcan in THYroid CancersWho this might be right forDifferentiated Thyroid CancerAnaplastic Thyroid Cancer Grupo Espanol de Tumores Neuroendocrinos 42